Epstein Secrets

k Meadows had tried to call him, but they had not connected, and Meadows had been in touch with some of his staff." The Wall Street Journal (10/22, Peterson, Subscription Publication, 7.57M) provides similar coverage. NEC Chief Economist Joe LaVorgna was asked on MSNBC' (10/22, 1.31M) about reports that

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

f his staff." The Wall Street Journal <https://www.wsj.com/articles/negotiators-defend- continuing-talks-on-coronavirus-aid-deal-11603403198> (10/22, Peterson, Subscription Publication, 7.57M) provides similar coverage. NEC Chief Economist Joe LaVorgna was asked on MSNBC <https://playvideo.bulletinintell

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

rk Meadows had tried to call him, but they had not connected, and Meadows had been in touch with some of his staff." The Wall Street Journal (10/22, Peterson, Subscription Publication, 7.57M) provides similar coverage. NEC Chief Economist Joe LaVorgna was asked on MSNBCVi (10/22, 1.31M) about reports th

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug